News Detail
Maryland, 8 March 2024: FDA announced on March 7, 2024 that the agency has published two final guidance documents regarding analytical procedures in order to facilitate regulatory evaluations and flexibility in postapproval change management of analytical procedures. The d......
View Details
Source : BioPharma International
final guidance documents
analytical procedures
Q2(R2)
Q14 Analytical Procedure DevelopmentÂ
Related News
- Fake degrees seized from pvt institute in Hisar (13-12-2024)
- Health ministry assign testing labs for surgical and medical examination gloves (13-12-2024)
- DCGI asks States to approve all applications for medicines and medical devices for rare diseases within three months (13-12-2024)
- Karnataka to restructure drugs control dept, strengthen procedures (13-12-2024)
- US FDA identifies cases of liver injury after treatment with Intercept's Ocaliva (obeticholic acid) (13-12-2024)
- Fake platelets sold for 15 thousand rupees in Prayagraj, CMO ordered an inquiry (12-12-2024)
- Cardiac drug sales signal increase in heart ailments (12-12-2024)
- Banned cough syrup worth Rs 15 lakh seized, driver arrested (12-12-2024)
- Sales in the respiratory market reached Rs 1,638 crore in November 2024 (12-12-2024)
- Kenya Govt Cautions Kenyans after Unregistered Cancer Drug Hits Market (12-12-2024)